July 2nd 2024 FDA Approves Tepylute for Breast and Ovarian Cancer Treatment https://www.onclive.com/view/fda-approves-tepylute-for-breast-and-ovarian-cancer-treatment
FDA approves Shorla Oncology’s TEPYLUTE for cancer treatmentJuly 2nd 2024Read More FDA approves Shorla Oncology’s TEPYLUTE for cancer treatment
Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian CancerJuly 2nd 2024Read More Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer
Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year FinalistsApril 24th 2024Read More Sharon Cunningham & Orlaith Ryan are 2024 EY Entrepreneur Of The Year Finalists
FDA Considers SH-201 for Treating Certain Leukemias and CancersApril 22nd 2024Read More FDA Considers SH-201 for Treating Certain Leukemias and Cancers